Skip to main content
Erschienen in: Der Kardiologe 2/2018

15.02.2018 | MitraClip-Behandlung | Positionspapier

Interventionelle Therapie von AV-Klappenerkrankungen – Fokus Mitralklappeninsuffizienz

Positionspapier der Deutschen Gesellschaft für Kardiologie

verfasst von: Prof. Dr. S. Baldus, Prof. Dr. K. H. Kuck, Prof. Dr. V. Rudolph, Prof. Dr. H. Nef, Prof. Dr. H. Eggebrecht, Prof. Dr. P. Boekstegers, Prof. Dr. J. Wöhrle, Prof. Dr. H. Ince, Prof. Dr. H. Möllmann, Prof. Dr. C. Stellbrink, Prof. Dr. J. Hausleiter, PD Dr. S. v. Bardeleben, Prof. Dr. M. Kelm, Prof. Dr. A Elsässer

Erschienen in: Die Kardiologie | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Zusammenfassung

Nach der Aortenklappenstenose stellen AV-Klappeninsuffizienzen (AV: atrioventrikular) die häufigsten Herzklappenfehler dar. Ätiologisch unterteilt in primäre und sekundäre Insuffizienzen ist die Behandlungsstrategie grundlegend unterschiedlich. Dies betrifft die Bedeutung und Dauer einer medikamentösen Therapie, den Zeitpunkt einer Intervention, die Frage nach Ersatz oder Rekonstruktion und die Wahl eines chirurgischen oder katheterinterventionellen Verfahrens. Im vergangenen Jahrzehnt hat sich die kathetergestützte Therapie besonders dynamisch entwickelt. So werden inzwischen mehr isolierte Mitralklappeninsuffizienzen mit einem katheterinterventionellen Verfahren behandelt als mittels rekonstruktiver Chirurgie. Auch sind mittlerweile erste kathetergestützte Behandlungen der Trikuspidalklappeninsuffizienz durchgeführt worden. In diesem Positionspapier werden die aktuell zur Verfügung stehenden katheterbasierten Verfahren zur Behandlung der Insuffizienz von Mitral- und Trikuspidalklappe zusammengefasst und ihr gegenwärtiger Stellenwert für die klinische Versorgung dargestellt. In Anbetracht der Prävalenz der Mitralinsuffizienz und der hohen Anzahl von in Deutschland durchgeführten Prozeduren an dieser Klappe hat sich die Deutsche Gesellschaft für Kardiologie entschieden, Qualitätskriterien für eine Zertifizierung von Zentren für die katheterinterventionelle Therapie der Mitralklappe zu definieren.
Fußnoten
1
Der einfacheren Lesbarkeit wegen wird auf die explizite Nennung beider Geschlechter verzichtet.
 
Literatur
1.
Zurück zum Zitat 28. Deutscher Herzbericht (2016) ISBN 978-3-9817032-5-2 28. Deutscher Herzbericht (2016) ISBN 978-3-9817032-5-2
2.
Zurück zum Zitat Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, Tornos P, Vanoverschelde J‑L, Vermeer F, Boersma E, Ravaud P, Vahanian A (2003) A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24:1231–1243CrossRefPubMed Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW, Tornos P, Vanoverschelde J‑L, Vermeer F, Boersma E, Ravaud P, Vahanian A (2003) A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 24:1231–1243CrossRefPubMed
3.
Zurück zum Zitat Jones EC, Devereux RB, Roman MJ, Liu JE, Fishman D, Lee ET, Welty TK, Fabsitz RR, Howard BV (2001) Prevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart Study). Am J Cardiol 87:298–304CrossRefPubMed Jones EC, Devereux RB, Roman MJ, Liu JE, Fishman D, Lee ET, Welty TK, Fabsitz RR, Howard BV (2001) Prevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart Study). Am J Cardiol 87:298–304CrossRefPubMed
4.
Zurück zum Zitat Levine RA, Hagége AA, Judge DP, Padala M, Dal-Bianco JP, Aikawa E, Beaudoin J, Bischoff J, Bouatia-Naji N, Bruneval P, Butcher JT, Carpentier A, Chaput M, Chester AH, Clusel C, Delling FN, Dietz HC, Dina C, Durst R, Fernandez-Friera L, Handschumacher MD, Jensen MO, Jeunemaitre XP, Le Marec H, Le Tourneau T, Markwald RR, Mérot J, Messas E, Milan DP, Neri T, Norris RA, Peal D, Perrocheau M, Probst V, Pucéat M, Rosenthal N, Solis J, Schott JJ, Schwammenthal E, Slaugenhaupt SA, Song JK, Yacoub MH, Leducq MTN (2015) Mitral valve disease – morphology and mechanisms. Nat Rev Cardiol 12:689–710CrossRefPubMedPubMedCentral Levine RA, Hagége AA, Judge DP, Padala M, Dal-Bianco JP, Aikawa E, Beaudoin J, Bischoff J, Bouatia-Naji N, Bruneval P, Butcher JT, Carpentier A, Chaput M, Chester AH, Clusel C, Delling FN, Dietz HC, Dina C, Durst R, Fernandez-Friera L, Handschumacher MD, Jensen MO, Jeunemaitre XP, Le Marec H, Le Tourneau T, Markwald RR, Mérot J, Messas E, Milan DP, Neri T, Norris RA, Peal D, Perrocheau M, Probst V, Pucéat M, Rosenthal N, Solis J, Schott JJ, Schwammenthal E, Slaugenhaupt SA, Song JK, Yacoub MH, Leducq MTN (2015) Mitral valve disease – morphology and mechanisms. Nat Rev Cardiol 12:689–710CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Bertrand PB, Schwammenthal E, Levine RA, Vandervoort PM (2017) Exercise dynamics in secondary mitral regurgitation: pathophysiology and therapeutic implications. Circulation 135:297–314CrossRefPubMedPubMedCentral Bertrand PB, Schwammenthal E, Levine RA, Vandervoort PM (2017) Exercise dynamics in secondary mitral regurgitation: pathophysiology and therapeutic implications. Circulation 135:297–314CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Benfari G, Dandale R, Rossi A, Onorati F, Mugnai G, Ribichini F, Temporelli PL, Vassanelli C (2016) Functional mitral regurgitation: are we treating the real target. J Cardiovasc Med (Hagerstown) 17:767–773CrossRef Benfari G, Dandale R, Rossi A, Onorati F, Mugnai G, Ribichini F, Temporelli PL, Vassanelli C (2016) Functional mitral regurgitation: are we treating the real target. J Cardiovasc Med (Hagerstown) 17:767–773CrossRef
7.
8.
Zurück zum Zitat Asgar AW, Mack MJ, Stone GW (2015) Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. J Am Coll Cardiol 65:1231–1248CrossRefPubMed Asgar AW, Mack MJ, Stone GW (2015) Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations. J Am Coll Cardiol 65:1231–1248CrossRefPubMed
9.
Zurück zum Zitat Huttin O, Voilliot D, Mandry D, Venner C, Juillière Y, Selton-Suty C (2016) All you need to know about the tricuspid valve: tricuspid valve imaging and tricuspid regurgitation analysis. Arch Cardiovasc Dis 109:67–80CrossRefPubMed Huttin O, Voilliot D, Mandry D, Venner C, Juillière Y, Selton-Suty C (2016) All you need to know about the tricuspid valve: tricuspid valve imaging and tricuspid regurgitation analysis. Arch Cardiovasc Dis 109:67–80CrossRefPubMed
10.
Zurück zum Zitat Pozzoli A, De Bonis M, Alfieri O (2016) Mitral valve repair. F1000Res 5 Pozzoli A, De Bonis M, Alfieri O (2016) Mitral valve repair. F1000Res 5
11.
Zurück zum Zitat Yanagawa B, Butany J, Verma S (2016) Update on rheumatic heart disease. Curr Opin Cardiol 31:162–168CrossRefPubMed Yanagawa B, Butany J, Verma S (2016) Update on rheumatic heart disease. Curr Opin Cardiol 31:162–168CrossRefPubMed
12.
Zurück zum Zitat Bouleti C, Juliard JM, Himbert D, Iung B, Brochet E, Urena M, Dilly MP, Ou P, Nataf P, Vahanian A (2016) Tricuspid valve and percutaneous approach: no longer the forgotten valve. Arch Cardiovasc Dis 109:55–66CrossRefPubMed Bouleti C, Juliard JM, Himbert D, Iung B, Brochet E, Urena M, Dilly MP, Ou P, Nataf P, Vahanian A (2016) Tricuspid valve and percutaneous approach: no longer the forgotten valve. Arch Cardiovasc Dis 109:55–66CrossRefPubMed
13.
Zurück zum Zitat Abramowitz Y, Jilaihawi H, Chakravarty T, Mack MJ, Makkar RR (2015) Mitral annulus calcification. J Am Coll Cardiol 66:1934–1941CrossRefPubMed Abramowitz Y, Jilaihawi H, Chakravarty T, Mack MJ, Makkar RR (2015) Mitral annulus calcification. J Am Coll Cardiol 66:1934–1941CrossRefPubMed
14.
Zurück zum Zitat Barbieri A, Bursi F, Grigioni F, Tribouilloy C, Avierinos JF, Michelena HI, Rusinaru D, Szymansky C, Russo A, Suri R, Bacchi Reggiani ML, Branzi A, Modena MG, Enriquez-Sarano M, Mitral RIDAMIDAI (2011) Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. Eur Heart J 32:751–759CrossRefPubMed Barbieri A, Bursi F, Grigioni F, Tribouilloy C, Avierinos JF, Michelena HI, Rusinaru D, Szymansky C, Russo A, Suri R, Bacchi Reggiani ML, Branzi A, Modena MG, Enriquez-Sarano M, Mitral RIDAMIDAI (2011) Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. Eur Heart J 32:751–759CrossRefPubMed
15.
Zurück zum Zitat Enriquez-Sarano M, Avierinos J‑F, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V, Scott C, Schaff HV, Tajik AJ (2005) Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 352:875–883CrossRefPubMed Enriquez-Sarano M, Avierinos J‑F, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V, Scott C, Schaff HV, Tajik AJ (2005) Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 352:875–883CrossRefPubMed
16.
Zurück zum Zitat Ling LH, Enriquez-Sarano M, Seward JB, Tajik AJ, Schaff HV, Bailey KR, Frye RL (1996) Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 335:1417–1423CrossRefPubMed Ling LH, Enriquez-Sarano M, Seward JB, Tajik AJ, Schaff HV, Bailey KR, Frye RL (1996) Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 335:1417–1423CrossRefPubMed
17.
Zurück zum Zitat Tribouilloy C, Grigioni F, Avierinos JF, Barbieri A, Rusinaru D, Szymanski C, Ferlito M, Tafanelli L, Bursi F, Trojette F, Branzi A, Habib G, Modena MG, Enriquez-Sarano M, Investigators MIDA (2009) Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study. J Am Coll Cardiol 54:1961–1968CrossRefPubMed Tribouilloy C, Grigioni F, Avierinos JF, Barbieri A, Rusinaru D, Szymanski C, Ferlito M, Tafanelli L, Bursi F, Trojette F, Branzi A, Habib G, Modena MG, Enriquez-Sarano M, Investigators MIDA (2009) Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study. J Am Coll Cardiol 54:1961–1968CrossRefPubMed
18.
Zurück zum Zitat Le Tourneau T, Messika-Zeitoun D, Russo A, Detaint D, Topilsky Y, Mahoney DW, Suri R, Enriquez-Sarano M (2010) Impact of left atrial volume on clinical outcome in organic mitral regurgitation. J Am Coll Cardiol 56:570–578CrossRefPubMed Le Tourneau T, Messika-Zeitoun D, Russo A, Detaint D, Topilsky Y, Mahoney DW, Suri R, Enriquez-Sarano M (2010) Impact of left atrial volume on clinical outcome in organic mitral regurgitation. J Am Coll Cardiol 56:570–578CrossRefPubMed
19.
Zurück zum Zitat Haan CK, Cabral CI, Conetta DA, Coombs LP, Edwards FH (2004) Selecting patients with mitral regurgitation and left ventricular dysfunction for isolated mitral valve surgery. Ann Thorac Surg 78:820–825CrossRefPubMed Haan CK, Cabral CI, Conetta DA, Coombs LP, Edwards FH (2004) Selecting patients with mitral regurgitation and left ventricular dysfunction for isolated mitral valve surgery. Ann Thorac Surg 78:820–825CrossRefPubMed
20.
Zurück zum Zitat Grigioni F, Avierinos J‑F, Ling LH, Scott CG, Bailey KR, Tajik AJ, Frye RL, Enriquez-Sarano M (2002) Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J Am Coll Cardiol 40:84–92CrossRefPubMed Grigioni F, Avierinos J‑F, Ling LH, Scott CG, Bailey KR, Tajik AJ, Frye RL, Enriquez-Sarano M (2002) Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J Am Coll Cardiol 40:84–92CrossRefPubMed
21.
Zurück zum Zitat Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Muñoz DR, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL (2017) 2017 ESC/EACTS Guidelines for the management of valvular heart disease: the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 38(36):2739–2791CrossRefPubMed Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Muñoz DR, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL (2017) 2017 ESC/EACTS Guidelines for the management of valvular heart disease: the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 38(36):2739–2791CrossRefPubMed
22.
Zurück zum Zitat Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O’Gara PT, Rigolin VH, Sundt TM, Thompson A (2017) 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation 35(25):1159–1195CrossRef Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O’Gara PT, Rigolin VH, Sundt TM, Thompson A (2017) 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation 35(25):1159–1195CrossRef
23.
Zurück zum Zitat Feldman T, Foster E, Glower DG, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L, Investigators TEVERESTII (2011) Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 364:1395–1406CrossRefPubMed Feldman T, Foster E, Glower DG, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L, Investigators TEVERESTII (2011) Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 364:1395–1406CrossRefPubMed
24.
Zurück zum Zitat Feldman T, Kar S, Elmariah S, Smart SC, Trento A, Siegel RJ, Apruzzese P, Fail P, Rinaldi MJ, Smalling RW, Hermiller JB, Heimansohn D, Gray WA, Grayburn PA, Mack MJ, Lim DS, Ailawadi G, Herrmann HC, Acker MA, Silvestry FE, Foster E, Wang A, Glower DD, Mauri L, EVEREST II Investigators (2015) Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5‑year results of EVEREST II. J Am Coll Cardiol 66:2844–2854CrossRefPubMed Feldman T, Kar S, Elmariah S, Smart SC, Trento A, Siegel RJ, Apruzzese P, Fail P, Rinaldi MJ, Smalling RW, Hermiller JB, Heimansohn D, Gray WA, Grayburn PA, Mack MJ, Lim DS, Ailawadi G, Herrmann HC, Acker MA, Silvestry FE, Foster E, Wang A, Glower DD, Mauri L, EVEREST II Investigators (2015) Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5‑year results of EVEREST II. J Am Coll Cardiol 66:2844–2854CrossRefPubMed
25.
Zurück zum Zitat Maisano F, Franzen O, Baldus S, Schäfer U, Hausleiter J, Butter C, Ussia GP, Sievert H, Richardt G, Widder JD, Moccetti T, Schillinger W (2013) Percutaneous mitral valve interventions in the real world: early and 1‑year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol 62:1052–1061CrossRefPubMed Maisano F, Franzen O, Baldus S, Schäfer U, Hausleiter J, Butter C, Ussia GP, Sievert H, Richardt G, Widder JD, Moccetti T, Schillinger W (2013) Percutaneous mitral valve interventions in the real world: early and 1‑year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol 62:1052–1061CrossRefPubMed
26.
Zurück zum Zitat Puls M, Lubos E, Boekstegers P, von Bardeleben RS, Ouarrak T, Butter C, Zuern CS, Bekeredjian R, Sievert H, Nickenig G, Eggebrecht H, Senges J, Schillinger W (2016) One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry. Eur Heart J 37:703–712CrossRefPubMed Puls M, Lubos E, Boekstegers P, von Bardeleben RS, Ouarrak T, Butter C, Zuern CS, Bekeredjian R, Sievert H, Nickenig G, Eggebrecht H, Senges J, Schillinger W (2016) One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry. Eur Heart J 37:703–712CrossRefPubMed
27.
Zurück zum Zitat Swaans MJ, van den Branden BJL, van der Heyden JAS, Post MC, Rensing BJWM, Eefting FD, Plokker HWM, Jaarsma W (2009) Three-dimensional transoesophageal echocardiography in a patient undergoing percutaneous mitral valve repair using the edge-to-edge clip technique. Eur J Echocardiogr 10:982–983CrossRefPubMed Swaans MJ, van den Branden BJL, van der Heyden JAS, Post MC, Rensing BJWM, Eefting FD, Plokker HWM, Jaarsma W (2009) Three-dimensional transoesophageal echocardiography in a patient undergoing percutaneous mitral valve repair using the edge-to-edge clip technique. Eur J Echocardiogr 10:982–983CrossRefPubMed
28.
Zurück zum Zitat Giannini C, Fiorelli F, De Carlo M, Guarracino F, Faggioni M, Giordano P, Spontoni P, Pieroni A, Petronio AS (2016) Comparison of percutaneous mitral valve repair versus conservative treatment in severe functional mitral regurgitation. Am J Cardiol 117:271–277CrossRefPubMed Giannini C, Fiorelli F, De Carlo M, Guarracino F, Faggioni M, Giordano P, Spontoni P, Pieroni A, Petronio AS (2016) Comparison of percutaneous mitral valve repair versus conservative treatment in severe functional mitral regurgitation. Am J Cardiol 117:271–277CrossRefPubMed
29.
Zurück zum Zitat Velazquez EJ, Samad Z, Al-Khalidi HR, Sangli C, Grayburn PA, Massaro JM, Stevens SR, Feldman TE, Krucoff MW (2015) The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: a propensity-matched comparison. Am Heart J 170:1050–1059.e3CrossRefPubMed Velazquez EJ, Samad Z, Al-Khalidi HR, Sangli C, Grayburn PA, Massaro JM, Stevens SR, Feldman TE, Krucoff MW (2015) The MitraClip and survival in patients with mitral regurgitation at high risk for surgery: a propensity-matched comparison. Am Heart J 170:1050–1059.e3CrossRefPubMed
30.
Zurück zum Zitat Smith PK, Hung JW, Michler RE (2015) Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med 372:1773–1774CrossRefPubMed Smith PK, Hung JW, Michler RE (2015) Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med 372:1773–1774CrossRefPubMed
31.
Zurück zum Zitat Nishimura RA, Vahanian A, Eleid MF, Mack MJ (2016) Mitral valve disease – current management and future challenges. Lancet 387:1324–1334CrossRefPubMed Nishimura RA, Vahanian A, Eleid MF, Mack MJ (2016) Mitral valve disease – current management and future challenges. Lancet 387:1324–1334CrossRefPubMed
32.
Zurück zum Zitat Stone GW, Vahanian AS, Adams DH, Abraham WT, Borer JS, Bax JJ, Schofer J, Cutlip DE, Krucoff MW, Blackstone EH, Généreux P, Mack MJ, Siegel RJ, Grayburn PA, Enriquez-Sarano M, Lancellotti P, Filippatos G, Kappetein AP, Mitral VARC (2015) Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles: a consensus document from the mitral valve academic research consortium. J Am Coll Cardiol 66:278–307CrossRefPubMed Stone GW, Vahanian AS, Adams DH, Abraham WT, Borer JS, Bax JJ, Schofer J, Cutlip DE, Krucoff MW, Blackstone EH, Généreux P, Mack MJ, Siegel RJ, Grayburn PA, Enriquez-Sarano M, Lancellotti P, Filippatos G, Kappetein AP, Mitral VARC (2015) Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 1: clinical trial design principles: a consensus document from the mitral valve academic research consortium. J Am Coll Cardiol 66:278–307CrossRefPubMed
33.
Zurück zum Zitat Boekstegers P, Hausleiter J, Baldus S, von Bardeleben RS, Beucher H, Butter C, Franzen O, Hoffmann R, Ince H, Kuck KH, Rudolph V, Schäfer U, Schillinger W, Wunderlich N (2013) Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system. Clin Res Cardiol 103(2):85–96CrossRef Boekstegers P, Hausleiter J, Baldus S, von Bardeleben RS, Beucher H, Butter C, Franzen O, Hoffmann R, Ince H, Kuck KH, Rudolph V, Schäfer U, Schillinger W, Wunderlich N (2013) Percutaneous interventional mitral regurgitation treatment using the Mitra-Clip system. Clin Res Cardiol 103(2):85–96CrossRef
34.
Zurück zum Zitat Lin BA, Forouhar AS, Pahlevan NM, Anastassiou CA, Grayburn PA, Thomas JD, Gharib M (2010) Color Doppler jet area overestimates regurgitant volume when multiple jets are present. J Am Soc Echocardiogr 23:993–1000CrossRefPubMed Lin BA, Forouhar AS, Pahlevan NM, Anastassiou CA, Grayburn PA, Thomas JD, Gharib M (2010) Color Doppler jet area overestimates regurgitant volume when multiple jets are present. J Am Soc Echocardiogr 23:993–1000CrossRefPubMed
35.
Zurück zum Zitat Lang RM, Badano LP, Tsang W, Adams DH, Agricola E, Buck T, Faletra FF, Franke A, Hung J, de Isla LP, Kamp O, Kasprzak JD, Lancellotti P, Marwick TH, McCulloch ML, Monaghan MJ, Nihoyannopoulos P, Pandian NG, Pellikka PA, Pepi M, Roberson DA, Shernan SK, Shirali GS, Sugeng L, Ten Cate FJ, Vannan MA, Zamorano JL, Zoghbi WA, Echocardiography EAO (2012) EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J Am Soc Echocardiogr 25:3–46CrossRefPubMed Lang RM, Badano LP, Tsang W, Adams DH, Agricola E, Buck T, Faletra FF, Franke A, Hung J, de Isla LP, Kamp O, Kasprzak JD, Lancellotti P, Marwick TH, McCulloch ML, Monaghan MJ, Nihoyannopoulos P, Pandian NG, Pellikka PA, Pepi M, Roberson DA, Shernan SK, Shirali GS, Sugeng L, Ten Cate FJ, Vannan MA, Zamorano JL, Zoghbi WA, Echocardiography EAO (2012) EAE/ASE recommendations for image acquisition and display using three-dimensional echocardiography. J Am Soc Echocardiogr 25:3–46CrossRefPubMed
36.
Zurück zum Zitat Alessandrini H, Kreidel F, Schlüter M, Frerker C, Schmidt T, Thielsen T, Schäfer U, Kuck KH (2017) Prognostic implication of post-MitraClip vena contracta area in heart-failure patients with functional mitral regurgitation. EuroIntervention 12(16):1946–1953CrossRefPubMed Alessandrini H, Kreidel F, Schlüter M, Frerker C, Schmidt T, Thielsen T, Schäfer U, Kuck KH (2017) Prognostic implication of post-MitraClip vena contracta area in heart-failure patients with functional mitral regurgitation. EuroIntervention 12(16):1946–1953CrossRefPubMed
37.
Zurück zum Zitat Gaemperli O, Biaggi P, Gugelmann R, Osranek M, Schreuder JJ, Bühler I, Sürder D, Lüscher TF, Felix C, Bettex DA, Grünenfelder J, Corti R (2013) Real-time left ventricular pressure: volume loops during percutaneous mitral valve repair with the MitraClip system. Circulation 127(9):1018–1027CrossRefPubMed Gaemperli O, Biaggi P, Gugelmann R, Osranek M, Schreuder JJ, Bühler I, Sürder D, Lüscher TF, Felix C, Bettex DA, Grünenfelder J, Corti R (2013) Real-time left ventricular pressure: volume loops during percutaneous mitral valve repair with the MitraClip system. Circulation 127(9):1018–1027CrossRefPubMed
38.
Zurück zum Zitat Horstkotte J, Kloeser C, Beucher H, Schwarzlaender E, von Bardeleben RS, Boekstegers P (2016) Intraprocedural assessment of mitral regurgitation during the mitraclip procedure: Impact of continuous left atrial pressure monitoring. Catheter Cardiovasc Interv 88:1134–1143CrossRefPubMed Horstkotte J, Kloeser C, Beucher H, Schwarzlaender E, von Bardeleben RS, Boekstegers P (2016) Intraprocedural assessment of mitral regurgitation during the mitraclip procedure: Impact of continuous left atrial pressure monitoring. Catheter Cardiovasc Interv 88:1134–1143CrossRefPubMed
39.
Zurück zum Zitat Feldman T, Wasserman HS, Herrmann HC, Gray W, Block PC, Whitlow P, Goar FSt, Rodriguez L, Silvestry F, Schwartz A, Sanborn TA, Condado JA, Foster E (2005) Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol 46:2134–2140CrossRefPubMed Feldman T, Wasserman HS, Herrmann HC, Gray W, Block PC, Whitlow P, Goar FSt, Rodriguez L, Silvestry F, Schwartz A, Sanborn TA, Condado JA, Foster E (2005) Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol 46:2134–2140CrossRefPubMed
40.
Zurück zum Zitat Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R, Whitlow PL, Gray W, Low R, Herrmann HC, Lim S, Foster E, Glower D, Investigators EVEREST (2009) Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 54:686–694CrossRefPubMed Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R, Whitlow PL, Gray W, Low R, Herrmann HC, Lim S, Foster E, Glower D, Investigators EVEREST (2009) Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 54:686–694CrossRefPubMed
41.
Zurück zum Zitat Maisano F, Taramasso M, Nickenig G, Hammerstingl C, Vahanian A, Messika-Zeitoun D, Baldus S, Huntgeburth M, Alfieri O, Colombo A, La Canna G, Agricola E, Zuber M, Tanner FC, Topilsky Y, Kreidel F, Kuck K‑H (2015) Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial. Eur Heart J 37(10):817–825CrossRefPubMed Maisano F, Taramasso M, Nickenig G, Hammerstingl C, Vahanian A, Messika-Zeitoun D, Baldus S, Huntgeburth M, Alfieri O, Colombo A, La Canna G, Agricola E, Zuber M, Tanner FC, Topilsky Y, Kreidel F, Kuck K‑H (2015) Cardioband, a transcatheter surgical-like direct mitral valve annuloplasty system: early results of the feasibility trial. Eur Heart J 37(10):817–825CrossRefPubMed
42.
Zurück zum Zitat Schofer J, Siminiak T, Haude M, Herrman JP, Vainer J, Wu JC, Levy WC, Mauri L, Feldman T, Kwong RY, Kaye DM, Duffy SJ, Tübler T, Degen H, Brandt MC, Van Bibber R, Goldberg S, Reuter DG, Hoppe UC (2009) Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation 120:326–333CrossRefPubMedPubMedCentral Schofer J, Siminiak T, Haude M, Herrman JP, Vainer J, Wu JC, Levy WC, Mauri L, Feldman T, Kwong RY, Kaye DM, Duffy SJ, Tübler T, Degen H, Brandt MC, Van Bibber R, Goldberg S, Reuter DG, Hoppe UC (2009) Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation 120:326–333CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Siminiak T, Wu JC, Haude M, Hoppe UC, Sadowski J, Lipiecki J, Fajadet J, Shah AM, Feldman T, Kaye DM, Goldberg SL, Levy WC, Solomon SD, Reuter DG (2012) Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial. Eur J Heart Fail 14:931–938CrossRefPubMedPubMedCentral Siminiak T, Wu JC, Haude M, Hoppe UC, Sadowski J, Lipiecki J, Fajadet J, Shah AM, Feldman T, Kaye DM, Goldberg SL, Levy WC, Solomon SD, Reuter DG (2012) Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial. Eur J Heart Fail 14:931–938CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Gammie JS, Wilson P, Bartus K, Gackowski A, Hung J, D’Ambra MN, Kolsut P, Bittle GJ, Szymanski P, Sadowski J, Kapelak B, Bilewska A, Kusmierczyk M, Ghoreishi M (2016) Transapical beating-heart mitral valve repair with an expanded polytetrafluoroethylene cordal implantation device: initial clinical experience. Circulation 134:189–197CrossRefPubMed Gammie JS, Wilson P, Bartus K, Gackowski A, Hung J, D’Ambra MN, Kolsut P, Bittle GJ, Szymanski P, Sadowski J, Kapelak B, Bilewska A, Kusmierczyk M, Ghoreishi M (2016) Transapical beating-heart mitral valve repair with an expanded polytetrafluoroethylene cordal implantation device: initial clinical experience. Circulation 134:189–197CrossRefPubMed
46.
Zurück zum Zitat Bouleti C, Fassa A‑A, Himbert D, Brochet E, Ducrocq G, Nejjari M, Ghodbane W, Depoix J‑P, Nataf P, Vahanian A (2015) Transfemoral implantation of transcatheter heart valves after deterioration of mitral bioprosthesis or previous ring annuloplasty. Jacc Cardiovasc Interv 8:83–91CrossRefPubMed Bouleti C, Fassa A‑A, Himbert D, Brochet E, Ducrocq G, Nejjari M, Ghodbane W, Depoix J‑P, Nataf P, Vahanian A (2015) Transfemoral implantation of transcatheter heart valves after deterioration of mitral bioprosthesis or previous ring annuloplasty. Jacc Cardiovasc Interv 8:83–91CrossRefPubMed
47.
Zurück zum Zitat Guerrero M, Dvir D, Himbert D, Urena M, Eleid M, Wang DD, Greenbaum A, Mahadevan VS, Holzhey D, O’Hair D, Dumonteil N, Rodés-Cabau J, Piazza N, Palma JH, DeLago A, Ferrari E, Witkowski A, Wendler O, Kornowski R, Martinez-Clark P, Ciaburri D, Shemin R, Alnasser S, McAllister D, Bena M, Kerendi F, Pavlides G, Sobrinho JJ, Attizzani GF, George I, Nickenig G, Fassa A‑A, Cribier A, Bapat V, Feldman T, Rihal C, Vahanian A, Webb J, O’Neill W (2016) Transcatheter mitral valve replacement in native mitral valve disease with severe mitral annular calcification: results from the first multicenter global registry. Jacc Cardiovasc Interv 9:1361–1371CrossRefPubMed Guerrero M, Dvir D, Himbert D, Urena M, Eleid M, Wang DD, Greenbaum A, Mahadevan VS, Holzhey D, O’Hair D, Dumonteil N, Rodés-Cabau J, Piazza N, Palma JH, DeLago A, Ferrari E, Witkowski A, Wendler O, Kornowski R, Martinez-Clark P, Ciaburri D, Shemin R, Alnasser S, McAllister D, Bena M, Kerendi F, Pavlides G, Sobrinho JJ, Attizzani GF, George I, Nickenig G, Fassa A‑A, Cribier A, Bapat V, Feldman T, Rihal C, Vahanian A, Webb J, O’Neill W (2016) Transcatheter mitral valve replacement in native mitral valve disease with severe mitral annular calcification: results from the first multicenter global registry. Jacc Cardiovasc Interv 9:1361–1371CrossRefPubMed
48.
Zurück zum Zitat Paradis J‑M, Del Trigo M, Puri R, Rodés-Cabau J (2015) Transcatheter valve-in-valve and valve-in-ring for treating aortic and mitral surgical prosthetic dysfunction. J Am Coll Cardiol 66:2019–2037CrossRefPubMed Paradis J‑M, Del Trigo M, Puri R, Rodés-Cabau J (2015) Transcatheter valve-in-valve and valve-in-ring for treating aortic and mitral surgical prosthetic dysfunction. J Am Coll Cardiol 66:2019–2037CrossRefPubMed
49.
Zurück zum Zitat Seiffert M, Conradi L, Baldus S, Schirmer J, Knap M, Blankenberg S, Reichenspurner H, Treede H (2012) Transcatheter mitral valve-in-valve implantation in patients with degenerated bioprostheses. Jacc Cardiovasc Interv 5:341–349CrossRefPubMed Seiffert M, Conradi L, Baldus S, Schirmer J, Knap M, Blankenberg S, Reichenspurner H, Treede H (2012) Transcatheter mitral valve-in-valve implantation in patients with degenerated bioprostheses. Jacc Cardiovasc Interv 5:341–349CrossRefPubMed
50.
Zurück zum Zitat Ye J, Cheung A, Yamashita M, Wood D, Peng D, Gao M, Thompson CR, Munt B, Moss RR, Blanke P, Leipsic J, Dvir D, Webb JG (2015) Transcatheter aortic and mitral valve-in-valve implantation for failed surgical bioprosthetic valves: an 8‑year single-center experience. Jacc Cardiovasc Interv 8:1735–1744CrossRefPubMed Ye J, Cheung A, Yamashita M, Wood D, Peng D, Gao M, Thompson CR, Munt B, Moss RR, Blanke P, Leipsic J, Dvir D, Webb JG (2015) Transcatheter aortic and mitral valve-in-valve implantation for failed surgical bioprosthetic valves: an 8‑year single-center experience. Jacc Cardiovasc Interv 8:1735–1744CrossRefPubMed
51.
Zurück zum Zitat Dvir D (2012) TAVI for degenerative bioprosthetic surgical valves: results of the Global Valve-in-Valve registry. Presented at: EuroPCR. EuroPCR. Paris, France Dvir D (2012) TAVI for degenerative bioprosthetic surgical valves: results of the Global Valve-in-Valve registry. Presented at: EuroPCR. EuroPCR. Paris, France
52.
Zurück zum Zitat Muller DW, Farivar RS, Jansz P, Bae R, Walters D, Clarke A, Grayburn PA, Stoler RC, Dahle G, Rein KA, Shaw M, Scalia GM, Guerrero M, Pearson P, Kapadia S, Gillinov M, Pichard A, Corso P, Popma J, Chuang M, Blanke P, Leipsic J, Sorajja P, Tendyne GFTI (2017) Transcatheter mitral valve replacement for patients with symptomatic mitral regurgitation: a global feasibility trial. J Am Coll Cardiol 69:381–391CrossRefPubMed Muller DW, Farivar RS, Jansz P, Bae R, Walters D, Clarke A, Grayburn PA, Stoler RC, Dahle G, Rein KA, Shaw M, Scalia GM, Guerrero M, Pearson P, Kapadia S, Gillinov M, Pichard A, Corso P, Popma J, Chuang M, Blanke P, Leipsic J, Sorajja P, Tendyne GFTI (2017) Transcatheter mitral valve replacement for patients with symptomatic mitral regurgitation: a global feasibility trial. J Am Coll Cardiol 69:381–391CrossRefPubMed
53.
Zurück zum Zitat Blackstone EH, Suri RM, Rajeswaran J, Babaliaros V, Douglas PS, Fearon WF, Miller DC, Hahn RT, Kapadia S, Kirtane AJ, Kodali SK, Mack M, Szeto WY, Thourani VH, Tuzcu EM, Williams MR, Akin JJ, Leon MB, Svensson LG (2015) Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy. Circulation 131:1989–2000CrossRefPubMed Blackstone EH, Suri RM, Rajeswaran J, Babaliaros V, Douglas PS, Fearon WF, Miller DC, Hahn RT, Kapadia S, Kirtane AJ, Kodali SK, Mack M, Szeto WY, Thourani VH, Tuzcu EM, Williams MR, Akin JJ, Leon MB, Svensson LG (2015) Propensity-matched comparisons of clinical outcomes after transapical or transfemoral transcatheter aortic valve replacement: a placement of aortic transcatheter valves (PARTNER)-I trial substudy. Circulation 131:1989–2000CrossRefPubMed
54.
Zurück zum Zitat Frerker C, Schmidt T, Schlüter M, Bader R, Schewel J, Schewel D, Thielsen T, Kreidel F, Alessandrini H, Schlingloff F, Schäfer U, Kuck KH (2016) Transcatheter implantation of aortic valve prostheses into degenerated mitral valve bioprostheses and failed annuloplasty rings: outcomes according to access route and Mitral Valve Academic Research Consortium (MVARC) criteria. EuroIntervention 12:1520–1526CrossRefPubMed Frerker C, Schmidt T, Schlüter M, Bader R, Schewel J, Schewel D, Thielsen T, Kreidel F, Alessandrini H, Schlingloff F, Schäfer U, Kuck KH (2016) Transcatheter implantation of aortic valve prostheses into degenerated mitral valve bioprostheses and failed annuloplasty rings: outcomes according to access route and Mitral Valve Academic Research Consortium (MVARC) criteria. EuroIntervention 12:1520–1526CrossRefPubMed
55.
Zurück zum Zitat Topilsky Y, Khanna AD, Oh JK, Nishimura RA, Enriquez-Sarano M, Jeon YB, Sundt TM, Schaff HV, Park SJ (2011) Preoperative factors associated with adverse outcome after tricuspid valve replacement. Circulation 123:1929–1939CrossRefPubMed Topilsky Y, Khanna AD, Oh JK, Nishimura RA, Enriquez-Sarano M, Jeon YB, Sundt TM, Schaff HV, Park SJ (2011) Preoperative factors associated with adverse outcome after tricuspid valve replacement. Circulation 123:1929–1939CrossRefPubMed
56.
Zurück zum Zitat Nath J, Foster E, Heidenreich PA (2004) Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 43:405–409CrossRefPubMed Nath J, Foster E, Heidenreich PA (2004) Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 43:405–409CrossRefPubMed
57.
Zurück zum Zitat Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF (2002) Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 144:524–529CrossRefPubMed Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF (2002) Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J 144:524–529CrossRefPubMed
58.
Zurück zum Zitat Hahn RT, Zamorano JL (2017) The need for a new tricuspid regurgitation grading scheme. Eur Heart J Cardiovasc Imaging 18:1342–1343CrossRefPubMed Hahn RT, Zamorano JL (2017) The need for a new tricuspid regurgitation grading scheme. Eur Heart J Cardiovasc Imaging 18:1342–1343CrossRefPubMed
59.
Zurück zum Zitat Rodés-Cabau J, Taramasso M, O’Gara PT (2016) Diagnosis and treatment of tricuspid valve disease: current and future perspectives. Lancet 388(10058):2431–2442CrossRefPubMed Rodés-Cabau J, Taramasso M, O’Gara PT (2016) Diagnosis and treatment of tricuspid valve disease: current and future perspectives. Lancet 388(10058):2431–2442CrossRefPubMed
60.
Zurück zum Zitat Lauten A, Doenst T, Hamadanchi A, Franz M, Figulla HR (2014) Percutaneous bicaval valve implantation for transcatheter treatment of tricuspid regurgitation: clinical observations and 12-month follow-up. Circ Cardiovasc Interv 7:268–272CrossRefPubMed Lauten A, Doenst T, Hamadanchi A, Franz M, Figulla HR (2014) Percutaneous bicaval valve implantation for transcatheter treatment of tricuspid regurgitation: clinical observations and 12-month follow-up. Circ Cardiovasc Interv 7:268–272CrossRefPubMed
61.
Zurück zum Zitat Kapadia SR, Krishnaswamy A, Tuzcu EM (2017) Percutaneous therapy for tricuspid regurgitation: a new frontier for interventional cardiology. Circulation 135(19):1815–1818CrossRefPubMed Kapadia SR, Krishnaswamy A, Tuzcu EM (2017) Percutaneous therapy for tricuspid regurgitation: a new frontier for interventional cardiology. Circulation 135(19):1815–1818CrossRefPubMed
62.
Zurück zum Zitat Nickenig G, Kowalski M, Hausleiter J, Braun D, Schofer J, Yzeiraj E, Rudolph V, Friedrichs K, Maisano F, Taramasso M, Fam NP, Bianchi G, Bedogni F, Denti P, Alfieri O, Latib A, Colombo A, Hammerstingl C, Schueler R (2017) Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge: mitraclip technique. Circulation 135(19):1802–1814CrossRefPubMed Nickenig G, Kowalski M, Hausleiter J, Braun D, Schofer J, Yzeiraj E, Rudolph V, Friedrichs K, Maisano F, Taramasso M, Fam NP, Bianchi G, Bedogni F, Denti P, Alfieri O, Latib A, Colombo A, Hammerstingl C, Schueler R (2017) Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge: mitraclip technique. Circulation 135(19):1802–1814CrossRefPubMed
63.
Zurück zum Zitat Bekanntmachung eines Beschlusses des Gemeinsamen Bundesausschusses über eine Richtlinie zu minimalinvasiven Herzklappeninterventionen: Erstfassung. BAnz AT 24. Juli 2015 Bekanntmachung eines Beschlusses des Gemeinsamen Bundesausschusses über eine Richtlinie zu minimalinvasiven Herzklappeninterventionen: Erstfassung. BAnz AT 24. Juli 2015
64.
Zurück zum Zitat Schächinger V, Nef H, Achenbach S, Butter C et al (2015) Arbeitsanweisung in Herzkatheterlabor und Hybridoperationssaal. Kardiologe 9:29–34CrossRef Schächinger V, Nef H, Achenbach S, Butter C et al (2015) Arbeitsanweisung in Herzkatheterlabor und Hybridoperationssaal. Kardiologe 9:29–34CrossRef
65.
Zurück zum Zitat Boekstegers P, Hausleiter J, Baldus S, Bardeleben RS, Beucher H, Butter C, Franzen O, Hoffmann R, Ince H, Kuck KH, Rudolph V, Schäfer U, Schillinger W, Wunderlich N (2013) Interventionelle Behandlung der Mitralklappeninsuffizienz mit dem MitraClip®-Verfahren. Kardiologe 7:91–104CrossRef Boekstegers P, Hausleiter J, Baldus S, Bardeleben RS, Beucher H, Butter C, Franzen O, Hoffmann R, Ince H, Kuck KH, Rudolph V, Schäfer U, Schillinger W, Wunderlich N (2013) Interventionelle Behandlung der Mitralklappeninsuffizienz mit dem MitraClip®-Verfahren. Kardiologe 7:91–104CrossRef
66.
Zurück zum Zitat Kuck K‑H, Eggebrecht H, Elsässer A, Hamm C, Haude M, Ince H, Katus H, Möllmann H, Naber CK, Schunkert H, Thiele H, Werner N (2016) Qualitätskriterien zur Durchführung der kathetergestützten Aortenklappenimplantation (TAVI). Kardiologe 10:282–300CrossRef Kuck K‑H, Eggebrecht H, Elsässer A, Hamm C, Haude M, Ince H, Katus H, Möllmann H, Naber CK, Schunkert H, Thiele H, Werner N (2016) Qualitätskriterien zur Durchführung der kathetergestützten Aortenklappenimplantation (TAVI). Kardiologe 10:282–300CrossRef
Metadaten
Titel
Interventionelle Therapie von AV-Klappenerkrankungen – Fokus Mitralklappeninsuffizienz
Positionspapier der Deutschen Gesellschaft für Kardiologie
verfasst von
Prof. Dr. S. Baldus
Prof. Dr. K. H. Kuck
Prof. Dr. V. Rudolph
Prof. Dr. H. Nef
Prof. Dr. H. Eggebrecht
Prof. Dr. P. Boekstegers
Prof. Dr. J. Wöhrle
Prof. Dr. H. Ince
Prof. Dr. H. Möllmann
Prof. Dr. C. Stellbrink
Prof. Dr. J. Hausleiter
PD Dr. S. v. Bardeleben
Prof. Dr. M. Kelm
Prof. Dr. A Elsässer
Publikationsdatum
15.02.2018
Verlag
Springer Medizin
Erschienen in
Die Kardiologie / Ausgabe 2/2018
Print ISSN: 2731-7129
Elektronische ISSN: 2731-7137
DOI
https://doi.org/10.1007/s12181-018-0232-y

Weitere Artikel der Ausgabe 2/2018

Der Kardiologe 2/2018 Zur Ausgabe

Passend zum Thema

ANZEIGE

Leitlinien-Update und neue Pocket-Leitlinie vorgestellt von Prof. Möllmann

Die neue Leitlinie zur Behandlung von Herzklappenerkrankungen der European Society of Cardiology (ESC) und der European Association for Cardio-Thoracic Surgery (EACTS) ist ab jetzt als deutschsprachige Pocket-Leitlinien abrufbar. Die wichtigsten Neuerungen des Updates finden Sie hier von Prof. Dr. Helge Möllmann aus Dortmund für Sie zusammengefasst.

ANZEIGE

Expertenrat: Wer profitiert vom Vorhofohr-Verschluss

Der interventionelle Verschluss des linken Vorhofohrs ist eine in den Leitlinien empfohlene Alternative zur oralen Antikoagulation bei Menschen mit Vorhofflimmern. Bei welchen Patientinnen und Patienten Sie konkret an diese Alternative denken sollten – dazu gibt Kardiologe PD Dr. Zisis Dimitriadis alltagstaugliche Tipps.

ANZEIGE

Abbott Structural Heart

Content Hub

Wir helfen Menschen mit Strukturellen Herzerkrankungen ihre Lebensqualität zu verbessern. Entdecken Sie unser einzigartiges Produktportfolio für ihre Patienten.

Abbott Medical GmbH